Kevin Krenitsky

Kevin Krenitsky

Directeur/Membre du Conseil chez Lumicell, Inc.

57 ans
Health Technology
Health Services
Consumer Services

Profil

Kevin Krenitsky currently works at Lumicell, Inc., as Director from 2015.
Dr. Krenitsky also formerly worked at BioServe Biotechnologies Ltd., as Chief Executive Officer, Parkway Clinical Laboratories, Inc., as Chief Executive Officer, Stemina Biomarker Discovery, Inc., as Director, New York State Clinical Laboratory Association, Inc., as Director, SeraCare Life Sciences, Inc., as Senior Vice President, OpGen, Inc., as President from 2015 to 2016, Genomics Collaborative, Inc., as Senior Vice President, AdvanDx, Inc., as President, Enzo Clinical Labs, Inc., as President, and Foundation Medicine, Inc., as Chief Commercial Officer & Senior Vice President from 2013 to 2014.
Dr. Krenitsky received his undergraduate degree from the University of Scranton and doctorate degree from Sidney Kimmel Medical College.

Postes actifs de Kevin Krenitsky

SociétésPosteDébut
Directeur/Membre du Conseil 01/04/2015
Tous les postes actifs de Kevin Krenitsky

Anciens postes connus de Kevin Krenitsky

SociétésPosteFin
OPGEN, INC. President 31/08/2016
FOUNDATION MEDICINE INC Corporate Officer/Principal 02/12/2014
President -
President -
President -
Voir l'expérience en détail de Kevin Krenitsky

Formation de Kevin Krenitsky

Sidney Kimmel Medical College Doctorate Degree
University of Scranton Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kevin Krenitsky

Relations

37

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
OPGEN, INC.

Commercial Services

Entreprise privées10

Health Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Electronic Technology

Health Technology

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Kevin Krenitsky